CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(34 sites)
United States
Children's Hospital of Alabama, Birmingham, Alabama Phoenix Childrens Hospital, Phoenix, Arizona Children's Hospital Los Angeles, Los Angeles, California Children's Hospital of Orange County, Orange, California UCSF Medical Center-Mission Bay, San Francisco, California Last updated February 2026